Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Famlee is a private U.S. digital fertility care company focused on improving access to fertility evaluation and treatment outside the traditional IVF-first pathway. The company offers an at-home fertility protocol that combines multi-hormone lab testing, telehealth visits with fertility providers, customized prescriptions and supplements, medication delivery, and a fertility tracking app. Famlee positions its service as a lower-cost step-therapy or pre-IVF solution intended to identify and address hormone-related contributors to infertility and support whole-body reproductive health. More recently, the company has also expanded into Famlee 340B, a service model for hospital-based IVF clinics that combines 340B administration, discounted IVF medication access, and patient referral support. Overall, Famlee operates more as a commercial fertility-services and digital health company than as a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Famlee Fertility.